A detailed history of Highview Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Highview Capital Management LLC holds 6,763 shares of LLY stock, worth $5.06 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares
6,763
Previous 6,582 2.75%
Holding current value
$5.06 Million
Previous $5.96 Million 0.54%
% of portfolio
2.47%
Previous 2.51%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $139,757 - $173,763
181 Added 2.75%
6,763 $5.99 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $52,915 - $66,359
73 Added 1.12%
6,582 $5.96 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $119,032 - $159,248
-201 Reduced 3.0%
6,509 $5.06 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $163,334 - $192,549
311 Added 4.86%
6,710 $3.91 Million
Q3 2023

Oct 20, 2023

SELL
$434.7 - $599.3 $29,994 - $41,351
-69 Reduced 1.07%
6,399 $3.44 Million
Q2 2023

Jul 19, 2023

BUY
$350.74 - $468.98 $7,365 - $9,848
21 Added 0.33%
6,468 $3.03 Million
Q1 2023

Apr 26, 2023

SELL
$310.63 - $364.82 $694,568 - $815,737
-2,236 Reduced 25.75%
6,447 $2.21 Million
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $67,525 - $78,680
210 Added 2.48%
8,683 $3.18 Million
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $211,093 - $240,563
712 Added 9.17%
8,473 $2.74 Million
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $143,545 - $168,544
-515 Reduced 6.22%
7,761 $2.52 Million
Q1 2022

Apr 28, 2022

BUY
$234.69 - $291.66 $564,429 - $701,442
2,405 Added 40.96%
8,276 $2.37 Million
Q4 2021

Jan 28, 2022

BUY
$224.85 - $279.04 $1.32 Million - $1.64 Million
5,871 New
5,871 $1.62 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Highview Capital Management LLC Portfolio

Follow Highview Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highview Capital Management LLC with notifications on news.